A 41 year old nondiabetic, non hypertensive male was admitted in AHD through neurosurgery OPD with the complaints of left eye watering and left sided weakness for 1 month. MRI examination revealed a mass / lesion in the left prepontine cistern, left CP angle with extension to left middle cranial fossa which was histologically found to be chondroma, an extremely rare tumour in the above mentioned location.

flare cluster included Delaware, Delaware Bay area, and Chesapeake Bay area between 2003 and 2014. Maps were generated highlighting the study area, flares, and identified clusters from all analyses. The space-time effects of environmental and demographic variables on the identified clusters will be considered in subsequent analysis. Conclusions We describe the first space-time clusters of lupus organ-specific disease activity strongly supporting the role of environmental factors as drivers of lupus activity.

Molecular diagnosis is rapidly becoming an inseparable part of disease diagnosis. This cutting edge technology can be used to diagnose both infectious and malignant diseases as well as to help in determining drug dosage, tissue types for organ transplant and risk of inherent disorders. An added advantage is that it provides an indication of therapeutic choice, therapy response and disease prognosis. A survey was conducted among diagnostic laboratories and research institutes of Bangladesh to observe the existing range of molecular diagnostic tests in Bangladesh. It is found that though molecular tests started in diagnostics about 15 years before, range of tests is still very limited in the country. Challenges faced in establishing as well as sustaining these tests were noted and opinions recorded from stakeholders regarding further opportunities to improve this area. We found that challenges are limited knowledge on molecular tests among physicians, unfavorable custom regulations and inadequate after-sale support from suppliers, cost of the tests and strong advocacy and marketing strategies of neighboring countries. To overcome these challenges our recommendations are inclusion of molecular medicine in medical curriculum, dissemination of information about molecular tests to existing physician community, minimum custom duty and minimum profit margin by the stakeholders to reduce test price. In addition, review of policies regarding import and support of cutting edge technology in diagnostic sector with involvement of available experts in this field is essential to make this valuable sector viable.

Health care delivery is no longer a simple process of examining the patient and giving him a prescription. Over the years there has been rapid expansion in the various branches of health care services. As part of this expansion process and explosion of scientific medical knowledge, laboratory diagnosis has gained tremendous importance in today’s practice. Especially in our country since the beginning of 80’s we have been witnessing significant growth in laboratory services. Through quality management process the laboratory can ensure that the result being issued by the laboratory is reliable to allow decisions to be taken with confidence. Quality control and quality assurance are parts of quality management. Quality control is focused on fulfilling quality requirements, whereas quality assurance is focused on providing confidence that quality requirements are fulfilled. By utilizing quality control practices, a laboratory is able to find and correct flaws in the analytical processes of a lab before potentially incorrect patient results are released.Pulse Vol.8 January-December 2015 p.62-65

Background: To assess the evolution of the left ventricular mass index on echocardiography in candesartan-treated hypertension individuals with and without diabetes. Study Design: This is a cross-sectional comparative study. Place and Duration: The present study was conducted from June 2022 to February 2023. Methodology: A total of 120 male and female patients of 35-55 years of age, fulfilling inclusion and exclusion criteria were selected for this study and divided into two groups i.e. Group-A and Group B. In Group-A 60 diabetic type-2 hypertensive patients were considered while in Group B 60 non-diabetic hypertensive patients were included. Patients of both groups were treated with candesartan. Raw data was operated through SPSS version 2022 with the Mean standard deviation regression (Mean ± SD). Results: Significant changes (P≤0.05) in both groups were seen, the hypertensive diabetic patients showed Mean standard Deviation value (35.65 ± 5.93) whereas hypertensive non-diabetic patients showed Mean standard Deviation value (21.95 ± .48) respectively. Practical Implications: In the current study there was an echocardiographic comparison of left ventricular mass index changes in both diabetic and non-diabetic hypertensive patients was concluded with candesartan cilexetil. The findings of this clinical trial are so beneficial for hypertensive patients to manage their self. Practical implication This study compared the effect of candesartan on left ventricular mass index in hypertensive diabetic and non-diabetic patients. The results showed that candesartan was more effective in reducing left ventricular mass index in hypertensive diabetic patients. This study provides useful information for the management of hypertension in diabetic patients of the community. Conclusion: Candesartan reduced left ventricular mass index more in hypertensive diabetic as compared to non-diabetic hypertensive patients. Both diabetic and non-diabetic hypertensive patients had a reduction in blood pressure with candesartan. With the considerable BP drop, candesartan is a viable treatment for hypertensive diabetic patients. Keywords: Hypertensive, Diabetics, Candesartan and Left ventricular index, posterior wall thickness.